Drug Database
Back to search

Belgium· BE-AMP-SAM515333-00

Efatriten 600 mg - 200 mg - 245 mg

A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenz, registered in Belgium by EG. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedEfatriten 600 mg - 200 mg - 245 mgATCJ05AR06REGISTER NO.BE-AMP-SAM515333-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about efavirenzAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine, tenofovir disoproxil and efavirenz products by name

Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Efavirenz
Manufacturer
EG
Country
Belgium (BE)
ATC code
J05AR06
ATC class
Emtricitabine, tenofovir disoproxil and efavirenz
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    4126801
  • be_apb
    7726953

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check emtricitabine, tenofovir disoproxil and efavirenz against other medicinesHow interaction checks work

Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Emtricitabine, tenofovir disoproxil and efavirenz in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir disoproxil and efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Efavirenz Sandoz
  • Cyprus · Efavirenz Aurobindo
  • Germany · Efavirenz Aurobindo
  • Denmark · Efavirenz "sandoz", Efavirenz Aurobindo
  • Estonia · Efavirenz Sandoz
  • Spain · Efavirenz Aurovitas
  • Finland · Efavirenz Aurobindo, Efavirenz Sandoz
  • France · Efavirenz Arrow, Efavirenz Sandoz
  • United Kingdom (Northern Ireland) · Efavirenz Accord, Efavirenz Amarox
  • Iceland · Efavirenz Teva
  • Liechtenstein · Efavirenz Teva
  • Netherlands · Efavirenz Accord, Efavirenz Aurobindo
  • Norway · Efavirenz Sandoz, Efavirenz Teva
  • Portugal · Efavirenz Aurobindo, Efavirenz Farmoz
  • Sweden · Efavirenz Aurobindo, Efavirenz Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9d6679d0-d29a-496e-92d7-975b3d086bbb
GET /v1/drugs/9d6679d0-d29a-496e-92d7-975b3d086bbb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Efatriten 600 mg - 200 mg - 245 mg",
  "name_fr": "Efatriten 600 mg - 200 mg - 245 mg",
  "name_nl": "Efatriten 600 mg - 200 mg - 245 mg",
  "amp_code": "SAM515333-00",
  "strengths": [
    "600.0000",
    "200.0000",
    "600.0000",
    "300.6000",
    "200.0000",
    "200.0000",
    "245.0000",
    "600.0000",
    "300.6000",
    "300.6000",
    "245.0000",
    "245.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Efavirenz",
    "Emtricitabine",
    "Tenofovir Disoproxil Succinate",
    "Tenofovir Disoproxil",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Emtricitabine, Tenofovir Disoproxil and Efavirenz",
  "authorisation_numbers": [
    "BE515333"
  ]
}
API referenceMCP serverPlans

See everything about emtricitabine, tenofovir disoproxil and efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console